William Michael Kavanaugh - Net Worth and Insider Trading
William Michael Kavanaugh Net Worth
The estimated net worth of William Michael Kavanaugh is at least $14,474 dollars as of 2024-11-13. William Michael Kavanaugh is the CSO, Head Res.&Non-Clin. Dev. of CytomX Therapeutics Inc and owns about 13,917 shares of CytomX Therapeutics Inc (CTMX) stock worth over $14,474. Details can be seen in William Michael Kavanaugh's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William Michael Kavanaugh has not made any transactions after 2017-10-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William Michael Kavanaugh
William Michael Kavanaugh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William Michael Kavanaugh owns 2 companies in total, including CytomX Therapeutics Inc (CTMX) , and Five Prime Therapeutics Inc (FPRX) .
Click here to see the complete history of William Michael Kavanaugh’s form 4 insider trades.
Insider Ownership Summary of William Michael Kavanaugh
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2017-10-04 | CSO & Head Res.&Non-Clin. Dev. |
| FPRX | Five Prime Therapeutics Inc | 2014-08-22 | SVP & Chief Scientific Officer |
William Michael Kavanaugh Latest Holdings Summary
William Michael Kavanaugh currently owns a total of 1 stock. William Michael Kavanaugh owns 13,917 shares of CytomX Therapeutics Inc (CTMX) as of October 4, 2017, with a value of $14,474.
Latest Holdings of William Michael Kavanaugh
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2017-10-04 | 13,917 | 1.04 | 14,474 |
Holding Weightings of William Michael Kavanaugh
William Michael Kavanaugh Form 4 Trading Tracker
According to the SEC Form 4 filings, William Michael Kavanaugh has made a total of 0 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years. The most-recent trade in CytomX Therapeutics Inc is the sale of 48,368 shares on October 4, 2017, which brought William Michael Kavanaugh around $1 Million.
Insider Trading History of William Michael Kavanaugh
- 1
William Michael Kavanaugh Trading Performance
GuruFocus tracks the stock performance after each of William Michael Kavanaugh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William Michael Kavanaugh is 5.96%. GuruFocus also compares William Michael Kavanaugh's trading performance to market benchmark return within the same time period. The performance of stocks bought by William Michael Kavanaugh within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William Michael Kavanaugh's insider trading performs compared to the benchmark.
Performance of William Michael Kavanaugh
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.11 | | | | | |
| Relative Return to S&P 500(%) | -7.55 | | | | | |
William Michael Kavanaugh Ownership Network
Ownership Network List of William Michael Kavanaugh
Ownership Network Relation of William Michael Kavanaugh
William Michael Kavanaugh Owned Company Details
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
William Michael Kavanaugh is the CSO & Head Res.&Non-Clin. Dev. of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, William Michael Kavanaugh made no insider transaction in CytomX Therapeutics Inc (CTMX). Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 62,273 shares made by Sean A. Mccarthy , a net sale of 25,172 shares made by Marcia Belvin , and a net sale of 19,012 shares made by Lloyd A Rowland .
In summary, during the past 3 months, insiders sold 28,425 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 28,425 shares. During the past 18 months, 132,341 shares of CytomX Therapeutics Inc (CTMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,341 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
William Michael Kavanaugh Mailing Address
Above is the net worth, insider trading, and ownership report for William Michael Kavanaugh. You might contact William Michael Kavanaugh via mailing address: C/o Five Prime Therapeutics, Inc., Two Corporate Drive, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
